# NIH Reporter #1R43AG102309-01

RadBot: Next-Generation Drug Discovery for Environmental Stress Resistance Using Longevity Biology

**Recipient:** Ora Biomedical, Inc.

**Award Amount:** $299,783.00
**Ceiling:** $299,783.00

**Awarded:** September 17, 2026

**Identifier:** 1R43AG102309-01

Ora Biomedical, Inc. received NIH funding through the National Institute on Aging for a project developing and validating longevity-biology-based interventions to protect against UV damage and related aging effects.

### Description

Funding to develop small-molecule formulations that activate cellular longevity pathways to protect against ultraviolet-induced damage, using high-throughput screening and validation in human cell and animal models.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11409024)
